Drug Profile
Eprosartan
Alternative Names: eprosartan mesylate; Navixen; SKB 108566; SKF 108566; Teveten; Teveten SB; Tevetens; TevetenzLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Acrylates; Antihypertensives; Heart failure therapies; Imidazoles; Small molecules; Thiophenes
- Mechanism of Action Angiotensin type 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Essential hypertension
- Discontinued Heart failure; Renal failure